ATE5125T1 - Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren. - Google Patents

Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.

Info

Publication number
ATE5125T1
ATE5125T1 AT80302896T AT80302896T ATE5125T1 AT E5125 T1 ATE5125 T1 AT E5125T1 AT 80302896 T AT80302896 T AT 80302896T AT 80302896 T AT80302896 T AT 80302896T AT E5125 T1 ATE5125 T1 AT E5125T1
Authority
AT
Austria
Prior art keywords
sanguinaria
galangal
pharmaceutical composition
zinc chloride
paste
Prior art date
Application number
AT80302896T
Other languages
English (en)
Inventor
Keith Reginald Collins
Original Assignee
Orewa Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orewa Inc. filed Critical Orewa Inc.
Application granted granted Critical
Publication of ATE5125T1 publication Critical patent/ATE5125T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT80302896T 1979-08-23 1980-08-21 Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren. ATE5125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7929364 1979-08-23
EP80302896A EP0025649B1 (de) 1979-08-23 1980-08-21 Pharmazeutische Zusammensetzung, die Sanguinaria und Galangal enthält, zur Behandlung von Periodontitis und Tumoren

Publications (1)

Publication Number Publication Date
ATE5125T1 true ATE5125T1 (de) 1983-11-15

Family

ID=10507385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80302896T ATE5125T1 (de) 1979-08-23 1980-08-21 Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.

Country Status (7)

Country Link
US (1) US4335110A (de)
EP (1) EP0025649B1 (de)
AT (1) ATE5125T1 (de)
CA (1) CA1148864A (de)
DE (1) DE3065420D1 (de)
ES (1) ES494867A0 (de)
PT (1) PT71727B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU548560B2 (en) * 1980-05-20 1985-12-19 Vipont Laboratories Inc. Benzophenanthridine alkaloids as antimicrobial agents
US4590061A (en) * 1983-12-29 1986-05-20 Vipont Laboratories, Inc. Antimicrobial plaque disclosing agent
US4517172A (en) * 1983-12-29 1985-05-14 Vipont Laboratories, Inc. Plaque disclosing agent
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4592488A (en) * 1985-05-24 1986-06-03 Simon Gilbert I Method for the preparation of chemotherapeutic compositions for the treatment of periodontal disease, compositions therefor and use thereof
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US4683133A (en) * 1985-08-20 1987-07-28 Vipont Laboratories, Inc. Method for treating periodontal disease
US4767861A (en) * 1986-01-28 1988-08-30 Vipont Laboratories Recovery of benzo-c-phenanthridine alkaloids
US4769452A (en) * 1986-02-07 1988-09-06 Vipont Laboratories, Inc. Production of purity benzo-c-phenanthridine alkaloid salts
US4689216A (en) * 1986-03-20 1987-08-25 Vipont Laboratories, Inc. Sanguinarine dental compositions with hydrated silica
ATE94052T1 (de) * 1986-10-21 1993-09-15 Smith Collins Pharma Oralisches reinigungsmittel.
US5175000A (en) * 1987-06-30 1992-12-29 Vipont Pharmaceutical, Inc. Free amine benzophenanthridine alkaloid compositions
FR2648047B2 (fr) * 1989-05-12 1994-09-02 Cariel Leon Produit polyphenolique a activite antivirale
FR2646852B1 (fr) * 1989-05-12 1992-03-20 Cariel Leon Produit polyphenolique a activite antivirale
EP0472531B1 (de) * 1989-05-12 1995-08-16 Cariel, Léon Zusammensetzung auf der basis von proanthocyanidolen und ihre pharmazeutische anwendung
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US5073368A (en) * 1991-05-15 1991-12-17 Colgate-Palmolive Company Sanguinaria mouthrinse having improved anti microbial activity and stability
AT403873B (de) * 1992-02-21 1998-06-25 Neufeld Klaus Dr Tierfutter zur leistungssteigerung
KR100413296B1 (ko) * 1996-10-31 2003-12-31 인터브루 맥주 맥아즙을 이용한 발효음료 및 그 제조방법
US6060079A (en) * 1998-09-09 2000-05-09 Freeman; Frank Device for topical localized administration of zinc to tissue
WO2000048541A1 (en) 1999-02-19 2000-08-24 Brooks Norman A Zinc chloride in treating skin diseases
US6231836B1 (en) * 1999-07-12 2001-05-15 Robert Takhtalian Folic acid dentifrice
AT500455B1 (de) * 2000-09-15 2007-08-15 Roth Hermann Dr Verwendung von benzophenanthridinalkaloiden als futteradditiv
AUPR726701A0 (en) * 2001-08-24 2001-09-20 HWF Enterprises Pty Ltd Compound for treatment of lesions and tumours
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
EP1993569B1 (de) 2006-02-03 2014-07-23 OMP, Inc. Behandlung gegen alterung mit kupfer- und zink-zusammensetzungen
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
KR101502465B1 (ko) * 2013-10-15 2015-03-13 한국 한의학 연구원 고량강 추출물을 포함하는 골 관련 질환 또는 혈관 석회화의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US209331A (en) * 1878-10-29 Improvement in medical compounds
US2344830A (en) * 1940-08-15 1944-03-21 Wisconsin Alumni Res Found Composition of matter for the chemical fixation of diseased tissue preparatory for surgical removal
US4145412A (en) * 1977-02-14 1979-03-20 Vipont Chemical Company Composition for application to oral cavity and method for preparation thereof
US4160821A (en) * 1978-02-27 1979-07-10 Johnson & Johnson Treatment for gingivitis

Also Published As

Publication number Publication date
PT71727B (en) 1981-06-25
ES8106654A1 (es) 1981-09-01
PT71727A (en) 1980-09-01
DE3065420D1 (en) 1983-12-01
EP0025649B1 (de) 1983-10-26
US4335110A (en) 1982-06-15
CA1148864A (en) 1983-06-28
EP0025649A1 (de) 1981-03-25
ES494867A0 (es) 1981-09-01

Similar Documents

Publication Publication Date Title
ATE5125T1 (de) Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.
MA20050A1 (fr) Nouveaux composes concernant des nouveaux sels d"omeprazole.
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
SE8303531D0 (sv) Farmaceutisk komposition
ES8101068A1 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
GB1518843A (en) Process for the preparation of hollow particulates
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
KR920702225A (ko) 약학 조성물
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
PH19980A (en) Benzenesulfonic esters of 2-uriidophenylthioureas,guanidines and substituted guanidines and pharmaceutical compositions containing them
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ATE15331T1 (de) Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen.
GB768046A (en) Improvements in or relating to dry sweetening compositions and method of making same
US2478984A (en) Medicinal preparation containing available calcium and phosphorus
FR2355844A1 (fr) Nouveaux composes pyrimido(1,2a)heterocycliques, procede de preparation de ces corps et compositions pharmaceutiques qui les contiennent
KR920005982A (ko) 피부질환용 약제조성물 및 그 제법
JPS62238214A (ja) 浴用剤
JPS565412A (en) Pharmaceutical composition
KR880012206A (ko) 구강질환 치료 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee